User:C11199E7890D0D46B0C758093DBD10A104C332EF4641929A518B790E81A1E798
User Enrollment: NonePosted Notes:1
-HELPFUL:0
-NOT HELPFUL:0
-NEEDS MORE RATINGS:1
Posted Ratings:0
-HELPFUL:0
-SOMEWHAT HELPFUL:0
-NOT HELPFUL:0
Posted Notes
2024-12-30 01:11:01
Vivek, founder of Roivant (NASDAQ: ROIV), led a firm that developed FDA-approved drugs. Axovant, a Roivant subsidiary, worked on an Alzheimer’s drug that failed—a fate shared by 99% of such drugs. Neither Vivek nor Roivant sold Axovant shares before its failure. [Link]
NEEDS_MORE_RATINGS(9-0-8)
Related notes[5]
Vivek, founder of Roivant (NASDAQ: ROIV), led a firm that developed FDA-approved drugs. Axovant, a Roivant subsidiary, worked on an Alzheimer’s drug that failed—a fate shared by 99% of such drugs. Neither Vivek nor Roivant sold Axovant shares before its failure. [Link]
NEEDS_MORE_RATINGS(9-0-8)
Related notes[5]
Rated Notes
